Gilead Sciences, Inc. ( GILD) - Stock Earnings
GILD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026, midnight | — / — | — | — / — | — |
GILD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 2.2 billion USD | 7.9 billion USD |
| 2026Q1 | 2.0 billion USD | 7.0 billion USD |
| 2026Q2 | -10.5 billion USD | 7.8 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GILD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.7 billion USD | 27.1 billion USD |
| 2024 | 480.0 million USD | 28.8 billion USD |
| 2025 | 8.5 billion USD | 29.4 billion USD |
| 2026 Est. | — | — |
GILD
List: Contenders
Price: $151.17
Dividend Yield: 2.25%
Forward Dividend Yield: 2.23%
Payout Ratio: 375.61%
Dividend Per Share: 3.28 USD
Earnings Per Share: -2.65 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 2.7 million
Ebitda: 2.4 billionMarket Capitalization: 179.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 12
DGR3: 2.69%
DGR5: 3.30%
DGR10: 16.73%